FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paulos Berhanu

Research Profile

Chemicals & Drugs

Anatomy

Concepts & Ideas

Kinetics

Living Beings

Disorders

Type 2 Diabetes Mellitus

Physiology

Occupations

Photochemistry

Genes & Molecular Sequences

Amino Acid Sequences

Co-author Network

Publications

TOP 3
Nirav Mamdani; Anita L Repp; Berhane Seyoum; Paulos Berhanu
Idiopathic hypoparathyroidism presenting with severe hypocalcemia and asymptomatic basal ganglia calcification followed by acute intracerebral bleed.
Akm Abdus Sattar; Chali Berhanu; Surafel Gebreselassie; Paulos Berhanu
Human insulin receptor juxtamembrane domain independent insulin signaling.
Paulos Berhanu; A Perez; S Yu
Effect of pioglitazone in combination with insulin therapy on glycaemic control, insulin dose requirement and lipid profile in patients with type 2 diabetes previously poorly controlled with combination therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paulos Berhanu (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Nirav Mamdani; Anita L Repp; Berhane Seyoum; Paulos Berhanu
Idiopathic hypoparathyroidism presenting with severe hypocalcemia and asymptomatic basal ganglia calcification followed by acute intracerebral bleed.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2007;13(5):487-92.
2007: Akm Abdus Sattar; Chali Berhanu; Surafel Gebreselassie; Paulos Berhanu
Human insulin receptor juxtamembrane domain independent insulin signaling.
Cell biology international 2007;31(8):815-24.
2007: Paulos Berhanu; A Perez; S Yu
Effect of pioglitazone in combination with insulin therapy on glycaemic control, insulin dose requirement and lipid profile in patients with type 2 diabetes previously poorly controlled with combination therapy.
Diabetes, obesity & metabolism 2007;9(4):512-20.
2007: Berhane Seyoum; Paulos Berhanu
Profile of diabetic ketoacidosis in a predominantly African American urban patient population.
Ethnicity & disease 2007;17(2):234-7.
2006: Berhane Seyoum; Raymond O Estacio; Paulos Berhanu; Robert W Schrier
Exercise capacity is a predictor of cardiovascular events in patients with type 2 diabetes mellitus.
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2006;3(3):197-201.
2006: Paulos Berhanu; Mark S Kipnes; Mehmood A Khan; Alfonso T Perez; Stuart F Kupfer; Robert C Spanheimer; Seleshi Demissie; Penny R Fleck
Effects of pioglitazone on lipid and lipoprotein profiles in patients with type 2 diabetes and dyslipidaemia after treatment conversion from rosiglitazone while continuing stable statin therapy.
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2006;3(1):39-44.
2003: Frederick G Hamel; Janet Fawcett; C I Andersen; Paulos Berhanu; Robert G Bennett; William C Duckworth
Insulin inhibition of protein degradation in cells expressing wild-type and mutant insulin receptors.
Journal of endocrinological investigation 2003;26(11):1088-94.
2003: Berhane Seyoum; Jemal Abdulkadir; Paulos Berhanu; Yeweyenhareg Feleke; Zerai Mengistu; Yoseph Worku; Gonfa Ayana
Analysis of serum lipids and lipoproteins in Ethiopian diabetic patients.
Ethiopian medical journal 2003;41(1):1-8.
2001: Marc L Goalstone; J Wayne Leitner; Paulos Berhanu; P M Sharma; J M Olefsky; Boris Draznin
Insulin signals to prenyltransferases via the Shc branch of intracellular signaling.
The Journal of biological chemistry 2001;276(16):12805-12.
2001: Berhane Seyoum; Z Mengistu; Paulos Berhanu; Jemal Abdulkadir; Yeweyenhareg Feleke; Yoseph Worku; Gonfa Ayana
Retinopathy in patients of Tikur Anbessa Hospital diabetic clinic.
Ethiopian medical journal 2001;39(2):123-31.
1999: Berhane Seyoum; Jemal Abdulkadir; Paulos Berhanu; F Feleke; Yoseph Worku; Gonfa Ayana
Profile of coronary artery risk factors in Ethiopian diabetic patients.
East African medical journal 1999;76(2):105-7.
1997: Paulos Berhanu; C Anderson; M Hickman; Theodore P Ciaraldi
Insulin signal transduction by a mutant human insulin receptor lacking the NPEY sequence. Evidence for an alternate mitogenic signaling pathway that is independent of Shc phosphorylation.
The Journal of biological chemistry 1997;272(36):22884-90.
1996: D B Schranz; A M Rohilla; C Anderson; William M Wood; Paulos Berhanu
Insulin internalization in the absence of the insulin receptor tyrosine kinase domain is insufficient for mediating intracellular biological effects.
Biochemical and biophysical research communications 1996;227(2):600-7.
1996: B Lynn Seely; P A Staubs; D R Reichart; Paulos Berhanu; K L Milarski; Alan Saltiel; J Kusari; Jerrold M Olefsky
Protein tyrosine phosphatase 1B interacts with the activated insulin receptor.
Diabetes 1996;45(10):1379-85.
1995: Paulos Berhanu; C Anderson; D R Paynter; William M Wood
The amino acid sequence GPLY is not necessary for normal endocytosis of the human insulin receptor B isoform.
Biochemical and biophysical research communications 1995;209(2):730-8.
1994: P A Staubs; D R Reichart; Alan Saltiel; K L Milarski; H Maegawa; Paulos Berhanu; Jerrold M Olefsky; B Lynn Seely
Localization of the insulin receptor binding sites for the SH2 domain proteins p85, Syp, and GAP.
The Journal of biological chemistry 1994;269(44):27186-92.
1991: Paulos Berhanu; R H Ibrahim-Schneck; C Anderson; William M Wood
The NPEY sequence is not necessary for endocytosis and processing of insulin-receptor complexes.
Molecular endocrinology (Baltimore, Md.) 1991;5(12):1827-35.
1991: A M Rohilla; C Anderson; William M Wood; Paulos Berhanu
Insulin downregulates the steady-state level of its receptor's messenger ribonucleic acid.
Biochemical and biophysical research communications 1991;175(2):520-6.
1990: Paulos Berhanu; A M Rohilla; W J Rutter
Replacement of the human insulin receptor transmembrane and cytoplasmic domains by corresponding domains of the oncogene product v-ros leads to accelerated internalization, degradation, and down-regulation.
The Journal of biological chemistry 1990;265(16):9505-11.
1988: Paulos Berhanu
Internalized insulin-receptor complexes are unidirectionally translocated to chloroquine-sensitive degradative sites. Dependence on metabolic energy.
The Journal of biological chemistry 1988;263(12):5961-9.
1987: A L Jochen; Paulos Berhanu
Insulin-stimulated glucose transport and insulin internalization share a common postbinding step in adipocytes.
Diabetes 1987;36(4):542-5.
1987: Paulos Berhanu; D J Saunders; D Brandenburg
Adipocyte insulin receptor. Generation of a cryptic domain of the alpha-subunit during internalization of hormone-receptor complexes.
The Biochemical journal 1987;242(2):589-96.
1987: A Jochen; Paulos Berhanu
Effects of metalloendoprotease inhibitors on insulin binding, internalization and processing in adipocytes.
Biochemical and biophysical research communications 1987;142(1):205-12.
1986: A L Jochen; Paulos Berhanu
Chymotrypsin substrate analogues inhibit endocytosis of insulin and insulin receptors in adipocytes.
The Journal of cell biology 1986;103(5):1807-16.
1986: A L Jochen; Paulos Berhanu; J M Olefsky
Insulin internalization and degradation in adipocytes from normal and type II diabetic subjects.
The Journal of clinical endocrinology and metabolism 1986;62(2):268-74.
1985: T Ciaraldi; R Robbins; J W Leidy; P Thamm; Paulos Berhanu
Insulin receptors on cultured hypothalamic cells: functional and structural differences from receptors on peripheral target cells.
Endocrinology 1985;116(6):2179-85.
1984: Kim A Heidenreich; D Brandenburg; Paulos Berhanu; J M Olefsky
Metabolism of photoaffinity-labeled insulin receptors by adipocytes. Role of internalization, degradation, and recycling.
The Journal of biological chemistry 1984;259(10):6511-5.
1983: Paulos Berhanu; O G Kolterman; A Baron; P Tsai; J M Olefsky; D Brandenburg
Insulin receptors in isolated human adipocytes. Characterization by photoaffinity labeling and evidence for internalization and cellular processing.
The Journal of clinical investigation 1983;72(6):1958-70.
1983: Kim A Heidenreich; Paulos Berhanu; D Brandenburg; J M Olefsky
Degradation of insulin receptors in rat adipocytes.
Diabetes 1983;32(11):1001-9.
1983: Kim A Heidenreich; Nancy R Zahniser; Paulos Berhanu; D Brandenburg; J M Olefsky
Structural differences between insulin receptors in the brain and peripheral target tissues.
The Journal of biological chemistry 1983;258(14):8527-30.
1982: Paulos Berhanu; P Tsai; J M Olefsky
Insulin-stimulated glucose transport in cultured fibroblasts from normal and noninsulin-dependent (type II) diabetic human subjects.
The Journal of clinical endocrinology and metabolism 1982;55(6):1226-30.
1982: Paulos Berhanu; J M Olefsky; P Tsai; P Thamm; D Saunders; D Brandenburg
Internalization and molecular processing of insulin receptors in isolated rat adipocytes.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(13):4069-73.
1982: J M Olefsky; S Marshall; Paulos Berhanu; M Saekow; Kim A Heidenreich; A Green
Internalization and intracellular processing of insulin and insulin receptors in adipocytes.
Metabolism: clinical and experimental 1982;31(7):670-90.
1982: Paulos Berhanu; J M Olefsky
Photoaffinity labeling of insulin receptors in viable cultured human lymphocytes. Demonstration of receptor shedding and degradation.
Diabetes 1982;31(5 Pt 1):410-7.
1981: Paulos Berhanu; J M Olefsky
Effects of insulin and insulin-like agents on the glucose transport system of cultured human fibroblasts.
Diabetes 1981;30(6):523-9.
1980: Paulos Berhanu; M D Hollenberg
Epidermal growth factor-urogastrone receptor: selective alteration in simian virus 40 transformed mouse fibroblasts.
Archives of biochemistry and biophysics 1980;203(1):134-44.
1979: M D Hollenberg; J C Barrett; P O Ts'o; Paulos Berhanu
Selective reduction in receptors for epidermal growth factor-urogastrone in chemically transformed tumorigenic Syrian hamster embryo fibroblasts.
Cancer research 1979;39(10):4166-9.